![Sam Wertheimer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sam Wertheimer
Président chez
Poliwogg Regenerative Medicine Fund, Inc.
Profil
Sam P.
Wertheimer is the founder of Poliwogg, Inc., founded in 2012.
Current jobs include Chairman & Executive Vice President at Poliwogg Regenerative Medicine Fund, Inc. since 2014, Chairman at Brookline Capital Acquisition Corp.
II starting in 2025, and Chief Investment Officer, EVP & Managing Director at Poliwogg Advisers LLC since 2014.
Former jobs include Chairman & Chief Executive Officer at Brookline Capital Acquisition Corp., Director at Corus Pharma, Inc. from 2001 to 2006, Director at Salmedix, Inc. from 2004 to 2005, Director at ChemoCentryx, Inc. from 2001 to 2011, Director at Biodel, Inc. from 2006 to 2009, Director at Cerimon Pharmaceuticals, Inc., Director at InteKrin Therapeutics, Inc. from 2007 to 2010, Director-Industrial Liaison at New York University School of Medicine Foundation from 1998 to 2000, Director at NeurAxon, Inc. from 2007 to 2010, Director at Apexigen, Inc. from 2022 to 2023, and Principal at OrbiMed Advisors Private Equity from 2000 to 2011.
Education includes undergraduate degree from The Johns Hopkins University, graduate degree from Yale University, and doctorate from New York University.
Postes actifs de Sam Wertheimer
| Sociétés | Poste | Début |
|---|---|---|
Poliwogg Regenerative Medicine Fund, Inc.
 Poliwogg Regenerative Medicine Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Président | - |
Poliwogg Advisers LLC
 Poliwogg Advisers LLC Investment ManagersFinance Provides investment advice | Directeur en chef des Investissements | 01/01/2014 |
Anciens postes connus de Sam Wertheimer
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Directeur/Membre du Conseil | 23/08/2023 |
Poliwogg, Inc. | Fondateur | 01/01/2016 |
| CHEMOCENTRYX, INC. | Directeur/Membre du Conseil | 01/01/2011 |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Directeur/Membre du Conseil | 01/01/2010 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Directeur/Membre du Conseil | 01/01/2010 |
Formation de Sam Wertheimer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Poliwogg Regenerative Medicine Fund, Inc.
Poliwogg Regenerative Medicine Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine Foundation | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Poliwogg Advisers LLC
Poliwogg Advisers LLC Investment ManagersFinance Provides investment advice | Finance |
Brookline Capital Acquisition Corp.
 Brookline Capital Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
Poliwogg, Inc. |
